BML 4.97 Decreased By ▼ -0.04 (-0.8%)
BOP 13.09 Increased By ▲ 0.01 (0.08%)
CNERGY 7.18 Increased By ▲ 0.06 (0.84%)
CPHL 86.71 Decreased By ▼ -0.74 (-0.85%)
DCL 14.38 Increased By ▲ 0.04 (0.28%)
DGKC 170.56 Decreased By ▼ -0.20 (-0.12%)
FCCL 46.70 Decreased By ▼ -0.06 (-0.13%)
FFL 15.98 Increased By ▲ 0.16 (1.01%)
GCIL 26.64 Decreased By ▼ -0.23 (-0.86%)
HUBC 147.87 Increased By ▲ 3.69 (2.56%)
KEL 5.33 Increased By ▲ 0.26 (5.13%)
KOSM 6.50 Decreased By ▼ -0.19 (-2.84%)
LOTCHEM 20.53 Decreased By ▼ -0.06 (-0.29%)
MLCF 84.83 Increased By ▲ 0.10 (0.12%)
NBP 126.35 Increased By ▲ 4.53 (3.72%)
PAEL 43.25 Decreased By ▼ -0.21 (-0.48%)
PIAHCLA 22.62 Increased By ▲ 0.33 (1.48%)
PIBTL 8.97 Increased By ▲ 0.04 (0.45%)
POWER 14.02 Increased By ▲ 0.01 (0.07%)
PPL 168.76 Decreased By ▼ -1.18 (-0.69%)
PREMA 42.60 Decreased By ▼ -0.79 (-1.82%)
PRL 33.18 Increased By ▲ 0.07 (0.21%)
PTC 24.02 Decreased By ▼ -0.24 (-0.99%)
SNGP 118.56 Decreased By ▼ -1.08 (-0.9%)
SSGC 46.18 Increased By ▲ 0.63 (1.38%)
TELE 8.26 Increased By ▲ 0.18 (2.23%)
TPLP 10.38 Decreased By ▼ -0.09 (-0.86%)
TREET 23.92 Decreased By ▼ -0.05 (-0.21%)
TRG 58.07 Increased By ▲ 0.02 (0.03%)
WTL 1.55 Increased By ▲ 0.03 (1.97%)
BR100 13,855 Increased By 224.4 (1.65%)
BR30 40,188 Increased By 337.2 (0.85%)
KSE100 136,503 Increased By 2202.8 (1.64%)
KSE30 41,553 Increased By 738.3 (1.81%)
World

EU regulator 'convinced' AstraZeneca jab benefits outweigh risks

  • The suspensions have provoked intense debate over whether it was prudent to put AstraZeneca inoculations on hold just as vaccination campaigns were beginning to gather pace.
Published March 17, 2021

THE HAGUE: The EU's medicines regulator said Tuesday it was "firmly convinced" the benefits of AstraZeneca's vaccine outweigh potential risks, insisting there was no evidence linking it to blood clots after several nations suspended the shot over health fears.

The suspensions have provoked intense debate over whether it was prudent to put AstraZeneca inoculations on hold just as vaccination campaigns were beginning to gather pace.

Experts at both the World Health Organization and the European Medicines Agency (EMA) met Tuesday to discuss the vaccine, with the European organisation expected to publish conclusions Thursday.

While millions of doses of the vaccine developed with Oxford University have been administered, small numbers of people have developed blood clots, prompting countries including the EU's three largest nations -- Germany, France and Italy -- to suspend injections.

The EMA insisted that countries should continue using the vaccine.

"We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing Covid-19 with its associated risk of hospitalisation and death outweigh the risk of these side effects," EMA chief Emer Cooke said Tuesday.

Cooke noted however that the regulator was "looking at adverse events associated with all vaccines".

France and Italy welcomed the news.

The preliminary statements from the EMA "are encouraging," read a joint statement from French President Emmanuel Macron and Italian Prime Minister Mario Draghi.

French Prime Minister Jean Castex vowed he would be vaccinated "very quickly" with the AstraZeneca vaccine to give the public confidence in the jab if it is ruled as safe by the EU medicines agency.

Castex also said that new restrictions could be put in place for the Paris region, such as the weekend lockdowns already imposed in the Nice and Calais regions.

"We are in a worrying and critical situation and, clearly, measures of the type that have been used in other parts of the territory are on the table," he told BFM TV in a live interview.

Comments

Comments are closed.